Skip to main content
  • NIH Jul 1, 1996 | R01

    The Genome Project and Technologies of Enhancement

    Principal Investigator(s): Rothman, David

    Institution: Columbia University

    FOA Number: N/A

    Abstract

    The goal of this project is to identify and analyze the challenges that genetic enhancements pose for American health policy and social policy. It will place genetics into the context of other medical technologies of enhancement, and, thereby, clarify the dynamics promoting their use and evaluate the strengths and weaknesses of regulatory practices. Although genetic enhancement is still in a fledgling state, technologies under development are soon likely to create new and powerful interventions. Accordingly, the project will conduct intensive analysis of three critical areas:
    - the discovery of hormones and the origins of enhancement technologies, 1900-1940;
    - the recent experience with physical enhancement through the use of growth hormones; and recent experience with performance enhancement through the use of psychopharmacological agents.
    The project will then apply the findings of this research to the public policy issues presented by genetic enhancement. The relevance and significance of this project rests in its presentation of a new and more comprehensive framework for understanding and responding to genetic enhancements.

    FUNDING AGENCY:

    Funder:
    NIH

    Institute:
    NATIONAL HUMAN GENOME RESEARCH INSTITUTE

    Funding Type:
    R01

    Project Number:
    R01HG001505

    Start Date:
    Jul 1, 1996

    End Date:
    Jun 30, 1997

    PROJECT TERMS:

Share

Related Projects

+ Show more related project Search results